Skip to Content

2 Results Found

  • Article
  • Open Access
6 Citations
3,294 Views
17 Pages

Neoadjuvant Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy for Muscle-Invasive Urothelial Cancer: Large, Single-Center Analysis of Consecutive Patients’ Data

  • Łukasz Kwinta,
  • Kamil Konopka,
  • Krzysztof Okoń,
  • Mateusz Łobacz and ,
  • Piotr Chłosta,
  • Przemysław Dudek,
  • Anna Buda-Nowak,
  • Paweł Potocki and
  • Piotr J. Wysocki
  • + 4 authors+ 0 author

14 January 2025

Background/Objectives: Bladder cancer is a significant clinical problem with approximately 500,000 new cases worldwide annually. In approximately 25% of cases, disease is diagnosed at a stage of invasion of the muscle layer of the bladder. The curren...

(This article belongs to the Special Issue New Insights into Urologic Oncology)
  • Article
  • Open Access
503 Views
15 Pages

Pretreatment NPLH as a Potential Predictor of Pathologic Complete Response to Accelerated MVAC Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Comparison with NLR and PLR

  • Łukasz Kwinta,
  • Kamil Konopka,
  • Krzysztof Okoń,
  • Mateusz Łobacz and ,
  • Maciej Lubaś,
  • Piotr Chłosta,
  • Przemysław Dudek and
  • Piotr J. Wysocki
  • + 3 authors+ 0 author

24 June 2026

Background. Accurate prediction of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in muscle-invasive urothelial bladder cancer (MIBC) remains an unmet clinical need. The neutrophil-to-platelet/hemoglobin-to-lymphocyte (NPLH) rat...

(This article belongs to the Section Cancer Therapy)